MENLO PARK (AP) - Facebook CEO Mark Zuckerberg reaped a gain of nearly $2.3 billion last year when he exercised 60 million stock options just before the online social networking leader's initial public offering.
NEW YORK (AP) - Amazon.com Inc.'s net income declined in the first three months of the year even though revenue increased 22 percent, as the online retailer continued to spend heavily on order fulfillment and rights to digital content.
DENVER (AP) - Medical and recreational marijuana may be legal in Colorado, but employers in the state can lawfully fire workers who test positive for the drug, even if it was used off duty, according to a court ruling Thursday.
SAN FRANCISCO (AP) - Zynga Inc.'s surprise profit in the first three months of the year got overshadowed by a revenue decline, a drop in the number of users and a lower-than-expected second-quarter forecast.
MOUNTAIN VIEW (AP) - Google CEO Larry Page and his longtime partner Sergey Brin limited their salaries to $1 apiece last year, while four other top executives received combined compensation packages totaling more than $124 million.
SAN FRANCISCO (AP) - Two San Francisco federal judges say juries will have to decide whether drivers for Uber and Lyft were independent contractors, or employees of the ride-hailing companies with all of the protections and benefits the state affords regular workers.
SANTA CLARA (AP) - Intel's stock fell Thursday after the giant chipmaker lowered its first-quarter revenue forecast, citing weak demand for business desktop PCs and a strong dollar that affects revenue from overseas sales.
WASHINGTON (AP) - Fake IRS agents have targeted more than 366,000 people with harassing phone calls demanding payments and threatening jail in the largest scam of its kind in the history of the agency, a federal investigator said Thursday.
WASHINGTON (AP) - The Food and Drug Administration is keeping a bold-letter warning on Pfizer's anti-smoking drug Chantix about suicidal behavior and other psychiatric side effects, after reviewing company findings suggesting the drug does not increase those problems.